The thiol reagent dithiothreitol inhibits the activity of a core GDP-fucose-N-acetylglucosaminide a-6-fucosyltransferase in plasma and blood-cell homogenates, while promoting the activity of a-2-and a-3-fucosyltransferases. The latter enzymes catalyse transfer of fucose on to terminal galactose and subterminal N-acetylglucosamine residues respectively. A thiol-blocking reagent N-ethylmaleimide does not affect the activity of the a-6-fucosyltransferase, but inhibits the other two enzymes. These results indicate the presence of a critical disulphide linkage in the a-6-fucosyltransferase, and provide a means of delineation of different fucosyltransferases.
The thiol reagent dithiothreitol inhibits the activity of a core GDP-fucose-N-acetylglucosaminide a-6-fucosyltransferase in plasma and blood-cell homogenates, while promoting the activity of a-2-and a-3-fucosyltransferases. The latter enzymes catalyse transfer of fucose on to terminal galactose and subterminal N-acetylglucosamine residues respectively. A thiol-blocking reagent N-ethylmaleimide does not affect the activity of the a-6-fucosyltransferase, but inhibits the other two enzymes. These results indicate the presence of a critical disulphide linkage in the a-6-fucosyltransferase, and provide a means of delineation of different fucosyltransferases.
At least three fucosyltransferases have been detected in human plasma or serum and these are also found in marrow and mature blood cells. An a-2-fucosyltransferase, specified by the H gene, catalyses transfer of fucose on to galactose residues of an appropriate acceptor (Bosmann et al., 1968; Schenkel-Brunner et al., 1972; Munro & Schachter, 1973; Pacuszka & Kosielak, 1974; Chester et al., 1976; Mulet et al., 1977; Schachter & Tilley, 1978 ). An a-3-fucosyltransferase mediates formation of a Fucal -3GlcNac linkage involving an N-acetylglucosamine residue subterminal to galactose (Schenkel-Brunner et al., 1972; Watkins, 1978) . Most investigators have measured a-2-and a-3-fucosyltransferase simultaneously by using an acceptor with Galal-÷4GlcNac configuration, e.g. N-acetyl-lactosamine (Schenkel-Brunner et al., 1972; Munro & Schachter, 1973) or a desialylated high-molecular-weight glycoprotein, e.g. fetuin or al-acid glycoprotein (Bosmann et al., 1968; Bella & Kim, 1971; Munro & Schachter, 1973; Munro et al., 1975; Kessel & Chou, 1976; Jabbal & Schachter, 1977; Chatterjee & Kim, 1978) . Phenyl f-galactoside was identified as a specific acceptor for a-2-fucosyltransferase activity (Chester et al., 1976) . A third plasma enzyme requires an acceptor with a terminal N-acetylglucosamine residue (Munro & Schachter, 1973) . This enzyme has also been found in tissues and blood cells (Bosmann et al., 1968; Bella & Kim, 1971; Kessel & Chou, 1976; Jabbal & Schachter, 1977; Chou et al., 1977; Chatterjee & Kim, 1978) and was found to catalyse transfer of fucose on to the 6'-position of an asparagine-linked N-acetylglucosamine residue in the glycoprotein core (Wilson et al., 1976) .
We reported preferential inhibition of a-2-and a-3-fucosyltransferases of plasma by the thiolAbbreviation used: Hepes, 4-(2-hydroxyethyl)-1-piperazine-ethanesulphonic acid. Vol. 181 blocking reagent N-ethylmaleimide; activity of the ac-6-fucosyltransferase was unaffected . This result indicated a method for delineation of N-ethylmaleimide-sensitive and -resistant fucosyltransferases in plasma, even in the presence of endogenous acceptors Khilanani et al., 1977 Khilanani et al., , 1978 . However, the a-2-and a-3-fucosyltransferases in blood-cell and marrow homogenates were found to be relatively resistant to N-ethylmaleimide. This study was initiated to determine whether other thiol reagents might affect the fucosyltransferase activities in such homogenates. The results also provide information on the nature of disulphide and thiol groups in the different enzymes.
Materials and Methods

GDP-L-['4C
]fucose (175 Ci/mol) was purchased from Amersham/Searle, Arlington Heights, IL, U.S.A. and New England Nuclear Corp., Boston, MA, U.S.A. Acceptors were obtained from Calbiochem Corp., Los Angeles, CA, U.S.A. Terminal sialic acid and subterminal galactose were removed from the glycoproteins as described by Spiro (1964) . Blood was anti-coagulated with EDTA, erythrocytes and platelets were removed by centrifugation, and the plasmas were stored at -70°C. Platelets from normal donors, lymphocytes from patients with chronic lymphocytic leukaemia, and peripheral and marrow myeloblasts from patients with acute myelogenous leukaemias were homogenized in 4vol. of 0.05M-Hepes buffer, pH7.0, containing 0.1 % Triton X-100.
Plasma fucosyltransferases were measured as described by Chou et al. (1977 Proteins were measured as described by Lowry et al. (1951) , with bovine serum albumin as standard.
Results and Discussion
The data shown in Table 1 provide an indication of the types and activities of fucosyltransferase in blood-cell homogenates. In all cases, endogenous acceptor activity was found to be present. Addition of the asialo-fetuin acceptor (terminal N-acetylglucosarnirte) strongly promoted transfer of fucose in the lymphocyte and platelet homogenates, indicating substantial a-6-fucosyltransferase activity in these preparations. In the myeloblast homogenate, fucose incorporation was stimulated by both asialoagalactofetuin and asialo-fetuin acceptors, indicating activity of both a-6-and a-2/3-fucosyltransferases. In contrast with results obtained with plasma, the activity detected with the asialo-fetuin acceptor was not inhibited by N-ethylmaleimide, but addition of dithiothreitol abolished a-6-fucosyltransferase in both plasma and cell homogenates.
We interpret the data shown in Table 1 to indicate the presence of endogenous acceptors of a-6-fucosyltransferase activity in the lymphocyte homogenate, but not in the other homogenates. With appropriate acceptors we can estimate total a-2/3-fucosyltransferase activity (asialo-fetuin acceptor, dithiothreitol present) and a-6-fucosyltransferase activity (asialoagalactofetuin acceptor, in the presence or absence of dithiothreitol).
Results obtained with different plasmas are shown in Table 2 . Dithiothreitol (20mM) inhibited the a-6-fucosyltransferase activity in plasma from a 'Bombay'-blood-group donor and from an acuteleukaemia patient in drug-induced remission. Plasmas from such patients contain elevated a-6-fucosyltransferase activity . The a-2/3-fucosyltransferase activity in plasma of an acute7myelogenous-leukaemia patient with more thAn 90% marrow myeloblasts was not affected by dithiothreitol. (Hoflack et al., 1978) . The ectoenzyme therefore resembles the corresponding enzyme in plasma, but not in the lymphocyte homogenate, in N-ethylmaleimide sensitivity. In another series of experiments, we found the rate of incorporation of fucose on to the different acceptors to be a linear function of incubation time, and of the amount of enzyme protein added. Liberation of fucose and fucose 1-phosphate, monitored by chromatography (Hoflack et al., 1978) , indicated less than 15 % substrate degradation by plasma and homogenates during incubation.
The present study indicates the presence of an important disulphide linkage in the a-6-fucosyltransferase of cells and plasma that is sensitive to reduction (Cleland, 1964) by dithiothreitol, whereupon activity is lost. Moreover, the N-ethylmaleimide-sensitive a-2/3-fucosyltransferase activity of a plasma sample that had decreased during 18 months of storage at low temperature was restored by dithiothreitol (Table 2 ). This finding, together with the sensitivity of the a-2/3 enzymes to N-ethylmaleimide, indicates that free thiol groups are essential for their activity.
